|Co- development offer for innovatve topical for Psoriasis|
|Written by Dr. Sanjay Banerji|
Innovatve topical for Psoriasis
We are interested in Co- development of an innovative topical formulation presented in a delivery system particularly targeted for treatment of Psoriasis and other dermatoses of hyperkeratotic nature. The formulation comprises of ingredients having anti inflammatory and a keratosolvent properties. The innovative formulation presented in a specially designed delivery system is patent potential and has superior clinical efficacy as compared to topical keratolytics such as Salicylic Acid, coal tar and synthetic retinoids.
We are open to any form of collaboration mutually beneficial and will be very pleased to make meaningful proceedings. Details on ingredients and system will be discussed on confidential basis. The formulation and method of application has been designed by the undersigned having wide clinical experience in clinical dermatology beside being an approved manufacturing chemist under Indian Drugs and Cosmetics Acts working in development of innovative topical.
Dr. Sanjay Banerji
For more information please contact Farmavita.Net team.Read also at Pharmaceutical Licensing Network
Newer news items
|< Prev||Next >|
Regulatory Affairs for EU & USA